Farren J. Isaacs' lab at Yale University focuses on understanding how proteins interact with each other and how their functions are modified by chemical changes called post-translational modifications (PTMs). By engineering bacteria to produce proteins with specific modifications, the lab aims to uncover the role of these modifications in crucial cellular processes and disease states. This pioneering work could lead to the development of new therapeutic strategies targeting diseases linked to protein interactions.

The lab led by Pasko Rakic at Yale University focuses on understanding how the primate cerebral cortex develops, especially the prefrontal cortex associated with cognitive disorders and addiction. By studying non-human primate models, the research aims to uncover key genetic and molecular mechanisms that drive cortical expansion and differentiation, which could inform treatments for cognitive impairments in humans. This work is notable for its implications in both theoretical neuroscience and clinical settings.

Dr. Srikant Rangaraju's lab at Yale University focuses on understanding the role of microglia, the brain's immune cells, in Alzheimer's disease (AD). By studying the proteins produced by these cells, the lab aims to uncover how neuroinflammation contributes to AD pathology and develop new biomarkers that can aid in diagnosis and treatment. They utilize innovative techniques like ciBONCAT to analyze protein changes in living models, providing fresh perspectives on this complex disease.

Dr. Steven K. Reilly's lab at Yale University focuses on understanding how variations in human DNA can affect traits and diseases. By studying and cataloging genetic mutations in regulatory regions of the genome, the lab aims to uncover the mechanisms behind these variations and improve predictions about their impacts on human health. The research combines advanced techniques like CRISPR and machine learning to investigate the complex interactions between genes and regulatory elements, leading to insights that could enhance our understanding of genetic diseases.

Dr. Karin M. Reinisch's lab at Yale University focuses on the molecular mechanisms behind how cells maintain and expand their membrane structures. The research emphasizes understanding how proteins facilitate the transfer of lipids between cellular organelles, a critical process for both cell function and the formation of new organelles, which has implications for understanding neurodegenerative diseases like Alzheimer's and Parkinson's.

Dr. Susan Baserga's lab at Yale University focuses on understanding the process of ribosome biogenesis and its links to human genetic diseases. They utilize innovative approaches, including genome-wide screening techniques, to identify proteins and non-coding RNAs that regulate ribosome production. By investigating how these processes affect cellular function in various tissues and during development, the lab aims to uncover the foundations of ribosomopathies, which are disorders tied to abnormal ribosome function.

Dr. Matthew Rodeheffer's lab at Yale University focuses on understanding the mechanisms behind obesity and its related diseases. The research particularly explores how the communication between endothelial cells and fat cells contributes to the accumulation and function of fat tissue. By studying hormones like estrogen and glucocorticoids in this context, the lab aims to develop new therapeutic strategies to combat obesity and associated metabolic disorders.

Dr. David Schatz's lab at Yale University studies how certain enzymes, specifically the RAG proteins, shape the immune system by cutting and rearranging DNA. These processes are essential for developing antibodies but can occasionally lead to mistakes that may result in blood cancers. The lab combines modern techniques in biochemistry, structural biology, and genetics to explore the intricate mechanisms of V(D)J recombination and somatic hypermutation in human cells.

Dr. Nenad Sestan's lab at Yale University focuses on understanding how the brain's cellular diversity affects aging and Alzheimer's disease. They study how specific cells in the hippocampal and entorhinal regions of the brain respond to Alzheimer's pathology and explore the molecular mechanisms behind this process. By employing advanced sequencing techniques, the lab aims to uncover patterns that may lead to better insights and treatments for Alzheimer's disease.

Dr. Valentina Greco's lab at Yale University focuses on understanding how skin tissue repairs itself after injury. They use advanced imaging techniques to observe and manipulate skin cells in live mice, allowing them to see how different types of cells cooperate during the healing process. The research aims to improve our understanding of wound healing, which is critical for treating chronic wounds and preventing skin cancer.

Dr. Yusuf Ransome's research lab focuses on understanding how social factors impact mental health and HIV outcomes in diverse communities. The lab investigates the relationships between social connectedness and mental health, particularly among Black adults and those from low-income backgrounds. Additionally, the lab develops methods to visualize and analyze data related to HIV prevention and care, aiming to enhance public health strategies in the United States.

Dr. Berna Sozen's lab at Yale University focuses on understanding early human embryonic development using advanced stem cell technology. By creating models of the human epiblast, her research aims to explore how cells differentiate into various types during embryogenesis and how factors like metabolism influence these processes. Ultimately, the lab's work seeks to provide insights into developmental disorders and contribute to more effective stem cell therapies.

The research lab led by Dr. Serena Spudich focuses on understanding how HIV affects the central nervous system (CNS) and contributes to cognitive and mental health issues in individuals living with HIV. They use advanced techniques to study HIV persistence in the brain, particularly in individuals on antiretroviral therapy (ART), and investigate how the immune response and viral characteristics relate to neuropsychiatric outcomes. This work aims to uncover new therapies that can enhance mental health for people living with HIV.

Dr. Stephen Strittmatter's lab at Yale University focuses on understanding the mechanisms of synapse loss in Alzheimer's disease. The research investigates how a specific receptor in the brain, called mGluR5, contributes to the disease's progression and memory impairment. By using advanced imaging techniques and genetic models, the lab aims to discover new therapeutic approaches to prevent synapse loss and improve brain function in Alzheimer's patients.

Dr. Pooja Khatri's lab at Yale University focuses on understanding how to better predict recovery outcomes for patients who have suffered a stroke, particularly concerning their upper extremity function. They are investigating the use of advanced imaging techniques and brain stimulation to identify patients who will benefit from specific treatments in the early stages after a stroke. This research aims to enhance personalized rehabilitation strategies for improving motor function in stroke survivors.

Dr. Yajaira Suarez's lab at Yale University studies how certain cellular processes in blood vessels and immune cells contribute to heart diseases, particularly atherosclerosis. They focus on understanding how non-coding RNAs and specific metabolic pathways influence the behavior of endothelial cells, smooth muscle cells, and macrophages in the context of vascular inflammation. The ultimate goal of this research is to uncover new treatment strategies for cardiovascular diseases through a better understanding of these mechanisms.

Dr. Hal Blumenfeld's lab at Yale University focuses on understanding how subcortical brain systems influence our perception across different senses like sight, sound, and touch. By analyzing brain activity during sensory experiences, they explore how transient increases in brain activity can enhance our awareness of these stimuli. Their research aims to uncover fundamental neural circuits that could help improve therapies for cognitive disorders that impair perception.

Dr. Zhaoxia Sun's lab at Yale University focuses on understanding the molecular mechanisms behind renal diseases and ciliary dysfunctions. The lab studies Nephronophthisis (NPHP), a genetic disorder leading to kidney cysts and fibrosis, and investigates how the assembly of dynein arms affects cilia motility, which is crucial for respiratory function. By combining mouse and zebrafish models with advanced genetic techniques, they aim to discover new therapeutic targets for these debilitating conditions.

Dr. Joerg Bewersdorf's lab at Yale University focuses on advancing super-resolution microscopy techniques to better visualize the intricate structures of cellular organelles. The research aims to understand how these structures change in diseases like cancer and neurodegenerative disorders. By developing innovative imaging tools, the lab strives to make it easier for scientists to explore the complexities of cellular biology and to improve public health outcomes through better diagnostic and therapeutic strategies.

Daniel A Colon-Ramos' lab at Yale University focuses on understanding the biology of synapses, which are crucial for communication between nerve cells and play a key role in how we learn and remember. The lab explores how synapses are formed and modified during development and learning, aiming to uncover the principles that govern behavior through neural circuitry. Their research not only deepens our understanding of basic neuroscience but also sheds light on conditions like neurodegeneration and disorders of brain development.